Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Terheyden, P; Houben, R; Pajouh, P; Thorns, C; Zillikens, D; Becker, JC.
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
J Invest Dermatol. 2010; 130(1):314-316
Doi: 10.1038/jid.2009.197
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Becker Jürgen Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents - therapeutic use
- Drug Resistance, Neoplasm - genetics
- Female -
- Humans -
- Melanoma - drug therapy Melanoma - genetics
- Middle Aged -
- Piperazines - therapeutic use
- Point Mutation -
- Proto-Oncogene Proteins c-kit - genetics
- Pyrimidines - therapeutic use
- Skin Neoplasms - drug therapy Skin Neoplasms - genetics